In addition, our results relating to the differing roles of CD8+ effector T cells in melanoma and NSCLC patients agree with previous reports that CD8+ effector T cells have a protective role in melanoma patients and no association with survival in NSCLC patients47, 48. Here, CD8A is linked to melanoma.